Pharmaniaga Eyes Foreign Purchase

May 2008 | Company News Alert

In order to further penetrate the largest pharmaceutical market in South East Asia, Malaysian firm Pharmaniaga is planning to purchase a medium-sized Indonesian drugmaker. The move is part of larger strategy of boosting its overseas presence, which itself is a hedge against a possible downturn in domestic sales. BMI endorses the plan and would encourage Pharmaniaga also to look at the Philippines, which has similar sized pharmaceutical market to Indonesia, but is growing quicker.

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.